TXG logo

TXG

10x Genomics Inc.

$24.62
+$0.93(+3.95%)
65
Overall
40
Value
90
Tech
65
Quality
How is this score calculated?
Market Cap
$1.62B
Volume
1.21M
52W Range
$8.31 - $26.45
Target Price
$24.85

Company Overview

Mkt Cap$1.62BPrice$24.62
Volume1.21MChange+3.95%
P/E Ratio-37.3Open$24.02
Revenue$642.8MPrev Close$23.68
Net Income$-43.5M52W Range$8.31 - $26.45
Div YieldN/ATarget$24.85
Overall65Value40
Quality65Technical90

No chart data available

About 10x Genomics Inc.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Sector: Healthcare
Industry: Healthcare

Latest News

Addentax Group Announces Related-Party Share Exchange Agreement

The latest announcement is out from Addentax Group ( ($ATXG) ). On May 15, 2026, Addentax Group Corp. agreed a related-party share exchange in whic...

TipRanks Auto-Generated Newsdesk5 days ago

Terex Corporation Earnings Call Signals Resilient Growth

TipRanks Auto-Generated Newsdesk7 days ago

Addentax Group Completes Share-Based Acquisition of Subsidiary

TipRanks Auto-Generated Newsdesk8 days ago

Torex Gold Earnings Call Highlights Cash-Fueled Momentum

TipRanks Auto-Generated Newsdesk15 days ago

10x Genomics (TXG) Gets a Buy from Canaccord Genuity

TipRanks Auto-Generated Intelligence Newsdesk18 days ago
ABCD
1SymbolPriceChangeVol
2TXG$24.62+3.9%1.21M
3
4
5
6

Get 10x Genomics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.